Patent tug-of-war continues
SAN DIEGO – Apex Medical has initiated challenges to four ResMed patents, it announced today. Apex has initiated challenges in the European Patent Office, the German Federal Patent Court, and the German Patent and Trade Mark Office. In November, ResMed won preliminary injunctions in Germany against Apex and Chinese manufacturer BMC Medical, prohibiting both manufacturers from selling or making certain products in Germany without a court order. In August, Apex asked the U.S. Patent and Trademark Office to reconsider the validity of six ResMed’s patents.